Biomea Fusion

BMEANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$132.645 M

$1.83 +2.23%

Close of 18 Sept 2026

Revenue

—

Not reported

Earnings

-$61.8M

Loss-making

Shares outstanding

72,483,852

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#290TuHURA BiosciencesHURA$133.8M
#291Unicycive TherapeuticsUNCY$133.7M
#292Biomea FusionBMEA$132.6M
#293Inovio PharmaceuticalsINO$128.2M
#294vTv TherapeuticsVTVT$125.7M

What if Biomea Fusion were worth as much as…

Open the what-if tool →

Gold $30.4T

$419,230.74

Per share 229,088× higher

Bitcoin $1.64T

$22,570.93

Per share 12,334× higher

Nvidia $5.36T

$73,902.07

Per share 40,384× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Biomea Fusion are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.